Utility of T2-weighted MRI to Differentiate Adrenal Metastases from Lipid-Poor Adrenal Adenomas.

Purpose: To evaluate T2-weighted MRI features to differentiate adrenal metastases from lipid-poor adenomas. Materials and Methods: With institutional review board approval, this study retrospectively compared 40 consecutive patients (mean age, 66 years ± 10 [standard deviation]) with metastases to 23 patients (mean age, 60 years ± 15) with lipid-poor adenomas at 1.5- and 3-T MRI between June 2016 and March 2019. A blinded radiologist measured T2-weighted signal intensity (SI) ratio (SInodule/SIpsoas muscle), T2-weighted histogram features, and chemical shift SI index. Two blinded radiologists (radiologist 1 and radiologist 2) assessed T2-weighted SI and T2-weighted heterogeneity using five-point Likert scales. Results: Subjectively, T2-weighted SI (P < .001 for radiologist 1 and radiologist 2) and T2-weighted heterogeneity (P < .001, for radiologist 1 and radiologist 2) were higher in metastases compared with adenomas when assessed by both radiologists. Agreement between the radiologists was substantial for T2-weighted SI (Cohen κ = 0.67) and T2-weighted heterogeneity (κ = 0.62). Metastases had higher T2-weighted SI ratio than adenomas (3.6 ± 1.7 [95% confidence interval {CI}: 0.2, 8.2] vs 2.2 ± 1.0 [95% CI: 0.6, 4.3], P < .001) and higher T2-weighted entropy (6.6 ± 0.6 [95% CI: 4.9, 7.5] vs 5.0 ± 0.8 [95% CI: 3.5, 6.6], P < .001). At multivariate analysis, T2-weighted entropy was the best differentiating feature (P < .001). Chemical shift SI index did not differ between metastases and adenomas (P = .748). Area under the receiver operating characteristic curve (AUC) for T2-weighted SI ratio and T2-weighted entropy were 0.76 (95% CI: 0.64, 0.88) and 0.94 (95% CI: 0.88, 0.99). The logistic regression model combining T2-weighted SI ratio with T2-weighted entropy yielded AUC of 0.95 (95% CI: 0.91, 0.99) and did not differ compared with T2-weighted entropy alone (P = .268). There was no difference in logistic regression model accuracy comparing the data by either field strength, 1.5- or 3-T MRI (P > .05). Conclusion: Logistic regression models combining T2-weighted SI and T2-weighted heterogeneity can differentiate metastases from lipid-poor adenomas. Validation of these preliminary results is required.Keywords: Adrenal, MR-Imaging, UrinarySupplemental material is available for this article.© RSNA, 2020.

Negative Predictive Value of Contrast-Enhanced Ultrasound of Liver and Kidney Thermal Ablation Sites for Local Tumour Progression During Long-term Follow-up: A Retrospective Consecutive Study.

PURPOSE: To determine negative predictive value (NPV) of contrast-enhanced ultrasound (CEUS) to demonstrate local tumour progression (LTP) at thermal ablation (TA) sites. METHODS: Our institutional review board approved this retrospective study; acquisition of consent was waived. Consecutive CEUS examinations performed between 2004-2014 for TA site evaluation on patients who could not undergo enhanced computed tomography (CT) or magnetic resonance imaging (MRI), or had inconclusive CT or MRI, were retrospectively reviewed. Those reported as no abnormal enhancement in or surrounding TA site were included. CEUS examination was considered true-negative based on stability or lack of enhancement/washout on follow-up imaging for at least 1 year, and false-negative (FN), if there was an arterially enhancing focus with wash-out at or surrounding TA site on subsequent follow-up imaging. RESULTS: Study population included 56 tumours in 54 patients, 11 women, 43 men; mean age 71 years. Two patients had TA of two different hepatocellular carcinomas. Thirty-six examinations were for hepatic TA and twenty for renal TA. Lesion sizes ranged from 1 cm to 7 cm (mean 3.1 ± 1.2). Mean diameter of 7 recurrences was 13.8 mm. Overall FN rate was 12.5% (7/56). Corresponding numbers were 0% (0/20) for renal TA and 19.4% (7/36) for hepatic TA. Overall NPV of CEUS was 87.5% (49/56) (confidence interval [CI]: 78.8%-96.2%). NPV for renal TA was 100% (20/20) (CI: 100%-100%) and for hepatic TA 81.5% (29/36) (CI: 67.6 %-93.5%). CONCLUSION: In this cohort, CEUS showed high NPV for exclusion of LTP at renal TA sites. NPV for hepatic TA sites was high but lower than renal TA.

Negative Predictive Value of Contrast-Enhanced Ultrasound in Differentiating Avascular Solid-Appearing From Vascularized Masses: A Retrospective Consecutive Study.

OBJECTIVES: To determine the negative predictive value (NPV) of contrast-enhanced ultrasound (CEUS) to establish the lack of vascularity in a mass. METHODS: This work was an Institutional Review Board-approved, Health Insurance Portability and Accountability Act-compliant retrospective study. Acquisition of consent was waived. We included all CEUS examinations performed for tissue characterization between 2004 and 2014 that reported showing no vascularity in a mass. Contrast-enhanced ultrasound findings were considered true-negative when there was stability on imaging for at least 1 year or no evidence of a solid mass, if biopsied, and false-negative if there was lesion growth on imaging within 12 months or an indication of a solid mass on the pathologic examination, if biopsied. One author reviewed all of the reports and follow-up examinations. We conducted a consensus review of all false-negative findings mixed with an equal number of true-negative findings by 2 reviewers, who were blinded to the final results. RESULTS: The study population consisted of 97 CEUS examinations in 97 patients, including 48 women and 49 men (mean age ± SD, 65 ± 14 years). Examinations were performed for lesion characterization in the liver (n = 23), pancreas (n = 17), kidney (n = 54), 1 gallbladder, 1 adnexa, and 1 peritoneal lesion. The overall false-negative rate on the official prospective review was 2% (2 of 97). Two false-negative findings were correctly identified on the consensus review. The NPV of CEUS was 97.9% (95 of 97; 95% confidence interval, 93%- 99%) on the official review. CONCLUSIONS: Contrast-enhanced ultrasound has a very high NPV to exclude the presence of flow in a mass, and it can be used to exclude the presence of a solid mass.

Utility of MRI to Differentiate Clear Cell Renal Cell Carcinoma Adrenal Metastases From Adrenal Adenomas.

OBJECTIVE: The purpose of this study is to compare MRI features of clear cell renal cell carcinoma (RCC) adrenal metastases and adenomas. MATERIALS AND METHODS: Fifteen clear cell RCC adrenal metastases imaged with MRI were compared to 29 consecutive adenomas between 2006 and 2015. Two blinded radiologists assessed homogeneity (homogeneous vs heterogeneous), signal intensity (SI) decrease on chemical-shift MRI, and T2-weighted SI (isointense, mildly hyperintense, or markedly hyperintense) relative to muscle. A third blinded radiologist measured the chemical-shift SI index, adrenal-to-spleen SI ratio, T2-weighted SI ratio, AUC for contrast-enhanced MRI, and histogram analysis. Analyses were performed using chi-square, linear regression, ROC, and logistic regression modeling. RESULTS: Clear cell RCC metastases were larger than adenomas (mean [± SD], 5.0 ± 4.2 cm [range, 1.1-15 cm] vs 2.0 ± 0.7 cm [range, 1.2-3.7 cm]; p < 0.0001). Subjectively, 33.3% (5/15) of metastases and 68.9% (20/29) of adenomas showed an SI decrease on chemical-shift MRI (p = 0.0421; κ = 0.76). Chemical-shift SI index (mean, 9.2% ± 20.6%; range, -30.0% to 57.9%) and adrenal-to-spleen SI ratio (0.94 ± 0.23 [range, 0.44-1.33]) for metastases differed significantly from those for adenomas (47.3% ± 27.8% [range, -9.4% to 86%] and 0.52 ± 0.28 [range, 0.13-1.11], respectively) (p < 0.0001). Twenty percent (3/15) of metastases had chemical-shift SI index in the adenoma range (> 16.5%). Metastases had higher T2-weighted SI than did adenomas, both quantitatively (5.1 ± 3.0 [range, 1.5-10.6] vs 1.8 ± 0.8 [range, 0.5-3.8]; p < 0.0001) and subjectively (p < 0.0001; κ = 0.89). Metastases had higher entropy than did adenomas (6.76 ± 0.61 vs 6.1 ± 0.74; p = 0.0051) and were subjectively more heterogeneous (p < 0.0001; κ = 0.86). The contrast-enhanced MRI AUC, skewness, and kurtosis did not differ between groups (p > 0.05). The ROC AUCs were 0.91 (95% CI, 0.79-1.0) for T2-weighted SI ratio and 0.85 (95% CI, 0.68-1.0) for entropy. The logistic regression model of T2-weighted SI ratio plus entropy improved accuracy (ROC AUC, 0.97; 95% CI, 0.93-1.0]) compared with either feature alone (p = 0.0215). CONCLUSION: Increased T2-weighted SI and heterogeneity are features that can differentiate clear cell RCC adrenal metastases from adenomas using quantitative and subjective analysis.

Comparison of high-resolution T1W 3D GRE (LAVA) with 2-point Dixon fat/water separation (FLEX) to T1W fast spin echo (FSE) in prostate cancer (PCa).

PURPOSE: To compare T1-weighted (T1W) fast spin echo (FSE) to T1W 3-dimensional gradient recalled echo (LAVA) with fat water separation (FLEX) in prostate cancer (PCa). METHODOLOGY: With institutional review board waiver, 39 patients underwent 3-T magnetic resonance imaging including T1W LAVA FLEX (157s)/T1W FSE (316s). Two radiologists assessed (a) image quality/sharpness, (b) presence/severity of artifacts, and (c) skeletal (N=22)/nodal (N=9) metastases. Results were compared using Wilcoxon signed-rank test/receiver operator characteristic analysis. RESULTS: With T1W LAVA FLEX, image quality/sharpness improved (P<.001) with less motion (P=.002-.03) and no difference in phase-encoding artifact (P>.05). One patient had moderate fat/water swap. Detection of skeletal metastases was unchanged (P>.05) and nodal metastases either improved (P=.002) or were comparable (P=.16) using T1W LAVA FLEX. CONCLUSION: T1W LAVA FLEX improves image quality, lessens motion artifact, and is comparable or improves detection of metastases in PCa with reduction in acquisition time.

Comparison of Quantitative MRI and CT Washout Analysis for Differentiation of Adrenal Pheochromocytoma From Adrenal Adenoma.

OBJECTIVE: The purpose of this study was to use quantitative analysis to assess MRI and washout CT in the diagnosis of pheochromocytoma versus adenoma. MATERIALS AND METHODS: Thirty-four pheochromocytomas (washout CT, 5; MRI, 24; both MRI and CT, 5) resected between 2003 and 2014 were compared with 39 consecutive adenomas (washout CT, 9; MRI, 29; both MRI and CT, 1). A blinded radiologist measured unenhanced attenuation, 70-second peak CT enhancement, 15-minute relative and absolute percentage CT washout, chemical-shift signal intensity index, adrenal-to-spleen signal intensity ratio, T2-weighted signal intensity ratio, and AUC of the contrast-enhanced MRI curve. Comparisons between groups were performed with multivariate and ROC analyses. RESULTS: There was no difference in age or sex between the groups (p > 0.05). For CT, pheochromocytomas were larger (4.2 ± 2.5 [SD] vs 2.3 ± 0.9 mm; p = 0.02) and had higher unenhanced attenuation (35.7 ± 6.8 HU [range, 24-48 HU] vs 14.0 ± 20.9 HU [range, -19 to 52 HU]; p = 0.002), greater 70-second peak CT enhancement (92.8 ± 31.1 HU [range, 41.0-143.1 HU] vs 82.6 ± 29.9 HU [range, 50.0-139.0 HU ]; p = 0.01), lower relative washout CT (21.7 ± 24.7 [range, -29.3 to 53.7] vs 65.3 ± 22.3 [range, 32.9-115.3]; p = 0.002), and lower absolute washout CT (31.9 ± 42.8 [range, -70.6 to 70.2] vs 76.9 ± 10.3 [range, 60.3-89.6]; p = 0.001). Thirty percent (3/10) of pheochromocytomas had absolute CT washout in the adenoma range (> 60%). For MRI, pheochromocytomas were larger (5.0 ± 4.2 vs 2.0 ± 0.7 mm; p = 0.003) and had a lower chemical-shift signal intensity index and higher adrenal-to-spleen signal intensity ratio (-3.5% ± 14.3% [range, -56.3% to 12.2%] and 1.1% ± 0.1% [range, 0.9-1.3%] vs 47.3% ± 27.8% [range, -9.4% to 86.0%] and 0.51% ± 0.27% [range, 0.13-1.1%]) (p < 0.001) and higher T2-weighted signal intensity ratio (4.4 ± 2.4 vs 1.8 ± 0.8; p < 0.001). There was no statistically significant difference in contrast-enhanced MRI AUC (288.9 ± 265.3 vs 276.2 ± 129.9 seconds; p = 0.96). The ROC AUC for T2-weighted signal intensity ratio was 0.91 with values greater than 3.8 diagnostic of pheochromocytoma. CONCLUSION: In this study, the presence of intracellular lipid on unenhanced CT or chemical-shift MR images was diagnostic of adrenal adenoma. Elevated T2-weighted signal intensity ratio was specific for pheochromocytoma but lacked sensitivity. There was overlap in all other MRI and CT washout parameters.